HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythropoietin course in newborns with Rh hemolytic disease transfused and not transfused in utero.

Abstract
This study reports the Hb, erythropoietin (Epo), and reticulocyte course at different postnatal ages (range, 8-83 d) of 56 blood samples from 30 newborns (range, one or two blood samples from each newborn) with erythroblastosis fetalis (18 intrauterine transfused (IUTd) and 12 non-IUTd). Hb, Epo, and reticulocyte values were not statistically different in IUTd and non-IUTd cases. As age increased, decreasing Hb values and increasing Epo levels were observed. The reticulocyte count was relatively low in all but six cases. There was an inverse correlation between Epo and Hb (r = -55, p < 0.001), but no correlation was found between Hb and reticulocytes or between Epo and reticulocytes. When groups were formed on the basis of Hb levels, anemic newborns showed higher serum Epo than did nonanemic patients (p < 0.02). In the present study we found a significant increase in Epo levels in anemic newborns without a rise in the reticulocyte count. These results suggest that other mechanisms, rather than low Epo production, could be involved in the pathogenesis of this anemia. Persisting anti-D antibodies, probably at a medullary level, may destroy erythrocyte precusors, leading to anemia with a low reticulocyte count.
AuthorsP Dallacasa, G Ancora, R Miniero, B Gavella, L Brondelli, R Conte, G P Salvioli
JournalPediatric research (Pediatr Res) Vol. 40 Issue 2 Pg. 357-60 (Aug 1996) ISSN: 0031-3998 [Print] United States
PMID8827790 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Hemoglobins
  • Erythropoietin
Topics
  • Aging (blood)
  • Analysis of Variance
  • Blood Transfusion, Intrauterine (methods)
  • Erythroblastosis, Fetal (blood, pathology)
  • Erythrocyte Transfusion (methods)
  • Erythropoietin (metabolism)
  • Hemoglobins (metabolism)
  • Humans
  • Infant, Newborn
  • Reticulocyte Count

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: